DARREN PERRY: Open Payments
NPI 1417982315 · MEDINA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,195 in 128 payments from 21 companies in 2025. Trend: 2023 $2,286 · 2024 $2,874 · 2025 $3,195
Food & beverage: $3,150Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $868 |
| Novo Nordisk Inc | 15 | $605 |
| Vanda Pharmaceuticals Inc. | 16 | $276 |
| PFIZER INC. | 15 | $197 |
| AstraZeneca Pharmaceuticals LP | 4 | $196 |
| Lilly USA, LLC | 9 | $194 |
| Axsome Therapeutics, Inc. | 4 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $173 |
| Ardelyx, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
Products named: VRAYLAR, Ozempic, Wegovy, QULIPTA, HETLIOZ, Kerendia, CREON, MOUNJARO.
Industry payments across TN — which companies pay providers there.
